Replies to post #429313 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

NOT an issue at all. JUST PURE FUD from a FUDster.

[frrol]

"Naked OR", good way to put it.

[bas2020]

More baseless nonsensical FUD from you...

Odds Ratios presented as a substitute for the trial population mean performance is exactly the issue. As secondary analysis/information Odds Ratios with n would tell a meaningful story. Anavex did not have the time to perform and present the full and hopeful secondary analysis at CTAD 2022.

Funny how FUDsters keep ignoring the mean scores provided and only focus on ORs, which astutely highlight the Super Responders.

[sokol]

In the Anavex 2b/3 Alzheimer's trial, were placebo patients typically allowed to continue taking their standard of care medication? I think I recall that in previous Anavex AD trials, placebo patients continued to take Donepezil(?). In the remdesivir clinical trial placebo patients received the stand of care and the odds ratio was used to compare remdesivir patients with standard of care placebo patients. Of course, that was the plan in remdesivir from the start of the trial and the trial participants numbered over 1,000. Therefore, the remdesivir trial may not be a valid comparison.